Tao Capital

Tracked participation in 2 Atlas companies, with 0 explicitly attributed leads.

2portfolio companies

2round participations

0lead positions

Apr 2022latest activity

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

CCrusoeNeocloudsCrusoe is an energy-first AI infrastructure company that builds and operates AI data center “factory” capacity and…$10Bvaluation$3.8BraisedRecent roundsSeries E (initial closing) · Oct 2025$1.4B · led by Mubadala Capital, Valor Equity PartnersCredit facility (debt) · Aug 2025$175M · led by Victory Park CapitalCredit facility (debt) · Jun 2025$750M · led by Brookfield Asset Management (infrastructure debt platform)Crusoe—Apr 2022 → Apr 20221 roundParticipant—

ITIambic TherapeuticsScienceIambic Therapeutics develops AI-native small-molecule medicines by combining (1) physics-informed neural models for…$8.4Mvaluation$258.5MraisedRecent roundsOversubscribed financing (round size disclosed as “over $100 million”) · Nov 2025$100M · Abingworth, Alexandria Venture Investments +16Series A · Jul 2021$53M · led by Catalio Capital Management, CoatueSeries Seed · Apr 2020$2.5M · Freeflow Ventures, Nexus Venture PartnersIambic Therapeutics—— → —1 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Apr 21, 2022CCrusoeNeocloudsCrusoe is an energy-first AI infrastructure company that builds and operates AI data center “factory” capacity and…$10Bvaluation$3.8BraisedRecent roundsSeries E (initial closing) · Oct 2025$1.4B · led by Mubadala Capital, Valor Equity PartnersCredit facility (debt) · Aug 2025$175M · led by Victory Park CapitalCredit facility (debt) · Jun 2025$750M · led by Brookfield Asset Management (infrastructure debt platform)CrusoeSeries C (equity offering)$350M—Participant

Source ↗

UndatedITIambic TherapeuticsScienceIambic Therapeutics develops AI-native small-molecule medicines by combining (1) physics-informed neural models for…$8.4Mvaluation$258.5MraisedRecent roundsOversubscribed financing (round size disclosed as “over $100 million”) · Nov 2025$100M · Abingworth, Alexandria Venture Investments +16Series A · Jul 2021$53M · led by Catalio Capital Management, CoatueSeries Seed · Apr 2020$2.5M · Freeflow Ventures, Nexus Venture PartnersIambic TherapeuticsSeries B$100M—Participant

Source ↗

DateCompanyRoundRaisedValuationRoleEvidence

Source ↗